Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 5Carcinoma, Transitional Cell 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Carcinoma, Hepatocellular 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Colorectal Neoplasms 2Stomach Neoplasms 1Sarcoma, Kaposi 1Recurrence 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Metastatic Squamous Non-Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1Mesothelioma 1Kidney Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Medullary 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Docetaxel 8pembrolizumab 7Pemetrexed 5Carboplatin 5Erlotinib Hydrochloride 4toripalimab 3rociletinib 3fludarabine 3Radiosurgery 3Paclitaxel 3Oxaliplatin 3Nivolumab 3Gemcitabine 3Etoposide 3Cyclophosphamide 3Cisplatin 3Bevacizumab 3lorlatinib 2atezolizumab 2Vinorelbine 2Topotecan 2Radiotherapy 2Platinum 2Itraconazole 2Irinotecan 2Interleukin-2 2Cetuximab 2Albumin-Bound Paclitaxel 2vinflunine 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × cabozantinib × Thoracic × Clear all
NCT01588821 2020-09-29

Cabozantinib in Advanced Solid Malignancies

Massachusetts General Hospital

Phase 2 Completed
37 enrolled 10 charts
GenitourinaryThoracic

Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡